Literature DB >> 21472690

Expression of cell-cycle regulatory proteins BUBR1, MAD2, Aurora A, cyclin A and cyclin E in invasive ductal breast carcinomas.

Juan Du1, Qiang Du, Yang Zhang, Constantin Sajdik, Yuan Ruan, Xin-xia Tian, Wei-gang Fang.   

Abstract

Cyclin A, cyclin E, BUBR1, MAD2 and Aurora A are all cell-cycle regulatory proteins and have been proven to play crucial roles in carcinogenesis. However, their expression patterns in invasive ductal breast carcinoma (IDBC) are controversial and unclear. In this study, we examined the expression status of these candidate proteins in a set of 117 invasive ductal carcinomas, and evaluated their associations with known clinicopathological parameters and the expressions of estrogen receptor, progesterone receptor, Ki-67 and Her-2. Univariate and multivariate data analyses both displayed that positive BUBR1 expression was associated with a high Ki-67 labeling index, and negative MAD2 expression was associated with Her-2 overexpression. Positive BUBR1 expression was also associated with a high histological tumor grade in univariate analysis, but not in multivariate analysis. In addition, high Aurora A expression was weakly associated with lymph node metastasis, and cyclin A was strongly associated with the expression of cyclin E in both univariate and multivariate models. In conclusion, this study suggests that evaluation of BUBR1, MAD2 and Aurora A expression levels is likely to improve accuracy of prognostic predictions in IDBC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472690     DOI: 10.14670/HH-26.761

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC).

Authors:  Liming Tan; Yuhong Zhang; Yongqing Jiang; Hua Li; Juanjuan Chen; Feng Ming; Waimei Wang; Jianlin Yu; Tingting Zeng; Yongjian Tian; Yang Wu
Journal:  Am J Clin Exp Immunol       Date:  2017-02-15

2.  Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Authors:  N Gurvits; H Repo; E Löyttyniemi; M Nykänen; J Anttinen; T Kuopio; K Talvinen; P Kronqvist
Journal:  Cell Oncol (Dordr)       Date:  2016-03-16       Impact factor: 6.730

3.  Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer.

Authors:  Yalcin Cirak; Yavuz Furuncuoglu; Ozlem Yapicier; Suleyman Alici; Andac Argon
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Breast cancer and protein biomarkers.

Authors:  Lay-Harn Gam
Journal:  World J Exp Med       Date:  2012-10-20

5.  Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Authors:  Cansu Karakas; Anna Biernacka; Tuyen Bui; Aysegul A Sahin; Min Yi; Said Akli; Jolie Schafer; Angela Alexander; Opoku Adjapong; Kelly K Hunt; Khandan Keyomarsi
Journal:  Am J Pathol       Date:  2016-05-13       Impact factor: 4.307

6.  Elevated BUBR1 expression is associated with poor survival in early breast cancer patients: 15-year follow-up analysis.

Authors:  Adam Maciejczyk; Jolanta Szelachowska; Bogdan Czapiga; Rafał Matkowski; Agnieszka Hałoń; Balázs Györffy; Paweł Surowiak
Journal:  J Histochem Cytochem       Date:  2013-02-07       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.